A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis
Status:
Completed
Trial end date:
2015-12-05
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to test the safety and efficacy of the oral
investigational new drug, SYM-1219 for the treatment of bacterial vaginosis.